WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

Consultant

SarahAdam

Sarah has worked as a researcher at the Advisory Board since 2018. During her time on the Oncology Roundtable team, she has contributed to research in cancer patient experience, employee engagement and patient navigation.

Sarah received her Masters in Management from the London School of Economics and her completed her undergraduate degree at Trinity College in Dublin, Ireland.

Have a Question?

x

Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.